Exact Mass: 269.0913
Exact Mass Matches: 269.0913
Found 82 metabolites which its exact mass value is equals to given mass value 269.0913,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-(2-Propoxyphenyl)-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
6-(CHLOROMETHYL)-4-(3-METHOXYPROPYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
3-(1H-BENZOIMIDAZOL-2-YL)-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHEN-2-YLAMINE
2-Chloro-6-methoxypyridine-4-boronic acid pinacol ester
tert-Butyl 4-chloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate
1,2,4-Triazolidine-3,5-dione,1,2,4-tris(2-oxiranylmethyl)-
2-(CHLOROACETYL)-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE
2′-Deoxy-2′-fluoroadenosine
2′-Deoxy-2′-fluoroadenosine can be used for the?synthesis?of 2′-Deoxy-2′-fluoro-modified oligonucleotides hybridized with RNA. 2′-Deoxy-2′-fluoroadenosine can be cleaved efficiently by E. coli purine nucleoside phosphorylase (PNP) to the toxic agent 2-fluoroadenine (FAde). 2′-Deoxy-2′-fluoroadenosine shows excellent in vivo activity against tumors expressing E. coli PNP[1].
5-Chloro-6-methoxypyridine-3-boronic acid pinacol ester
5-Chloro-2-methoxypyridine-3-boronic acid pinacol ester
ETHYL 4-CHLORO-2-(PIPERIDIN-1-YL)PYRIMIDINE-5-CARBOXYLATE
2-methyl-5-(pyrrolidin-1-ylsulfonyl)phenylboronic acid
tert-butyl 3-chloro-7,8-dihydro-5H-pyrido[4,3-c]pyridazine-6-carboxylate
6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE
3-Chloro-2-methoxypyridine-4-boronic acid pinacol ester
6-Chloro-2-methoxypyridine-3-boronic acid pinacol ester
tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
Ethyl 5-chloro-6-piperazin-1-ylpyridine-3-carboxylate
(2R,3R,5S)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol
Methyl 3-(2-amino-4-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridine-4-carb oxylate
tert-butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
METHYL 5-(ACETYLOXY)-4-(2-METHOXY-2-OXOETHYL)-2-METHYL-1H-PYRROLE-3-CARBOXYLATE
(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)- 2,3-Butanediol
2-Aminopurine-9-beta-D-(2-deoxy-2-fluoro)arabino-riboside
(4-Methyl-3-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
2-chloro-3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
ethyl 1-(6-chloropyridazin-3-yl)piperidine-4-carboxylate
N4-Acetyl-2-deoxycytidine
N-Acetyl-2′-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
METHYL 4-AMINO-5-BROMO-2-METHOXYBENZENECARBOXYLATE
(2-Methyl-4-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
ethyl 2-[tert-butoxycarbonylimino]-3,3,3-trifluoro-propionate
2-AMINO-6-BENZYL-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBONITRILE
Pardoprunox hydrochloride
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Pardoprunox (SLV-308) hydrochloride is a partial dopamine D2 and D3 receptor partial agonist and a serotonin 5-HT1A receptor agonist, with pEC50s of 8, 9.2, and 6.3, respectively[1].
5-(2-Propoxyphenyl)-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One
5-Methyl-2'-O,4'-C-methylenecytidine is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].
(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid
2-Amino-9-(2,3-dideoxy-3-fluoropentofuranosyl)-3,9-dihydro-6H-purin-6-one
2-[(prop-2-enylthio)-(4,5,6,7-tetrahydro-1H-indol-2-yl)methylidene]propanedinitrile
5-Isocyano-2-[[2-(methylaminomethyl)phenyl]thio]aniline
1-[(Z)-[(4-amino-1,2,5-oxadiazol-3-yl)hydrazinylidene]methyl]naphthalen-2-ol
3'-Deoxy-3'-fluoroadenosine
3'-Deoxy-3'-fluoroadenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
